IberiaBank’s Regeneron Pharmaceuticals REGN Stock Holding History

IberiaBank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$270K	Buy	+433	New	+$246K	0.03%	187
2018 Q1	–	Sell	-4,874	Closed	-$1.83M	–	241
2017 Q4	$1.83M	Buy	4,874 +81	+2%	+$32.8K	0.29%	105
2017 Q3	$2.14M	Buy	4,793 +367	+8%	+$175K	0.36%	86
2017 Q2	$2.17M	Buy	4,426 +458	+12%	+$200K	0.65%	56
2017 Q1	$1.54M	Buy	3,968 +2,595	+189%	+$962K	0.48%	74
2016 Q4	$504K	Buy	+1,373	New	+$522K	0.18%	95
2016 Q3	–	Sell	-952	Closed	-$332K	–	142
2016 Q2	$332K	Buy	952 +61	+7%	+$23.5K	0.15%	116
2016 Q1	$321K	Buy	891 +64	+8%	+$26.4K	0.15%	111
2015 Q4	$449K	Buy	827 +53	+7%	+$28.7K	0.2%	94
2015 Q3	$360K	Buy	774 +22	+3%	+$11.8K	0.18%	101
2015 Q2	$384K	Buy	752 +101	+16%	+$49.3K	0.17%	98
2015 Q1	$294K	Buy	651 +112	+21%	+$47.5K	0.13%	136
2014 Q4	$221K	Buy	+539	New	+$212K	0.12%	156

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IberiaBank's REGN Position: Q2 2020 in Review

IberiaBank opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2020: 433 shares worth $270K. The stake represents 0.03% of the portfolio and ranks #187 among its holdings. This is a return to the name: IberiaBank previously reported a position in REGN as recently as Q4 2017.

IberiaBank first reported a position in REGN in Q4 2014 and has held it in 13 quarters since. The position peaked at $2.17M in Q2 2017. 933 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

IberiaBank held 433 shares of Regeneron Pharmaceuticals worth $270K as of Q2 2020.
Regeneron Pharmaceuticals was a new IberiaBank position in Q2 2020.
Regeneron Pharmaceuticals made up 0.03% of IberiaBank's portfolio in Q2 2020, its #187 holding.
IberiaBank first reported a position in Regeneron Pharmaceuticals in Q4 2014 and has held it in 13 quarters since.
IberiaBank's Regeneron Pharmaceuticals position peaked at $2.17M in Q2 2017.
933 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on IberiaBank's 13F filing for Q2 2020, filed 29 Jul 2020.